AI
MYGN icon

Analytic Investors’s Myriad Genetics MYGN Stock Holding History

Analytic Investors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$633K Buy
+30,749
New +$780K 0.01% 442
2015
Q1 		– Sell
-13,555
Closed -$462K – 569
2014
Q4 		$462K Sell
13,555
-37,376
-73% -$1.33M 0.01% 430
2014
Q3 		$1.96M Buy
+50,931
New +$1.9M 0.03% 269
2014
Q2 		– Sell
-55,099
Closed -$1.88M – 573
2014
Q1 		$1.88M Sell
55,099
-123,823
-69% -$3.84M 0.03% 290
2013
Q4 		$3.75M Sell
178,922
-304,183
-63% -$7.69M 0.06% 196
2013
Q3 		$11.4M Buy
483,105
+454,355
+1,580% +$12.9M 0.18% 136
2013
Q2 		$773K Buy
+28,750
New +$833K 0.01% 383

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return